☆ 4.3 Review

Recent advances in the understanding of urothelial tumorigenesis

EXPERT REVIEW OF ANTICANCER THERAPY (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer

Jinqin Qian et al.

Summary: This study reveals the significant role of NFE2L3 in bladder cancer and suggests its potential as a valuable clinical prognostic biomarker and therapeutic target. NFE2L3 overexpression is associated with progression and metastasis of bladder cancer, and several mechanisms are involved.

CARCINOGENESIS (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Arsenic activates STAT3 signaling during the transformation of the human bronchial epithelial cells

Bandar Almutairy et al.

Summary: Arsenic, a metalloid found abundantly in the environment, is associated with various human cancers. This study explored the mechanisms of arsenic-induced carcinogenesis and found that exposure to different concentrations and durations of arsenic can increase the risk of lung cancer. Long-term exposure to arsenic can promote malignant transformation and alter the expression of certain genes and microRNAs. These findings provide insights into the cellular transformation process caused by arsenic.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2022)

添加到收藏夹

Article Oncology

KLF16 Downregulates the Expression of Tumor Suppressor Gene TGFBR3 to Promote Bladder Cancer Proliferation and Migration

Xiaosong Chen et al.

Summary: The study found that KLF16 acts as an oncogene in bladder cancer by transcriptional inactivation of TGFBR3. This study provides evidence that targeting the KLF16/TGFBR3 axis may be beneficial for bladder cancer patients.

CANCER MANAGEMENT AND RESEARCH (2022)

添加到收藏夹

Article Biochemical Research Methods

Analysis of six aromatic amines in the mainstream smoke of tobacco products

Huihua Ji et al.

Summary: A novel SPME headspace GC-MS/MS method was developed for quantifying six aromatic amines in tobacco smoke, demonstrating high sensitivity, simple sample preparation, and satisfactory linearity and accuracy for all compounds analyzed.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective

Yongsheng Zhang et al.

Summary: This review discusses TLR4 inhibitors that can bind directly to TLR4 or the TLR4/MD2 complex, as well as compounds that can downregulate the expression of TLR4. The involvement of specific residues in the binding of antagonistic ligands to the TLR4/MD2 complex provides useful information for structure-based TLR4 inhibitor design.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Multidisciplinary Sciences

A long noncoding RNA GTF2IRD2P1 suppresses cell proliferation in bladder cancer by inhibiting the Wnt/β-catenin signaling pathway

Zhuo Huang et al.

Summary: The expression of lncRNA GTF2IRD2P1 is found to be lower in bladder cancer tissues and cell lines, while elevated in certain bladder cancer cell lines. Overexpression of GTF2IRD2P1 inhibits the proliferation of bladder cancer cells and prolongs the cell cycle, while silencing GTF2IRD2P1 increases cell proliferation and shortens the cell cycle, promoting the progression of bladder cancer.

PEERJ (2022)

添加到收藏夹

Review Oncology

Molecular Oncology of Bladder Cancer from Inception to Modern Perspective

Soum D. Lokeshwar et al.

Summary: Bladder cancer is a common and deadly disease, and the study of molecular oncology has greatly contributed to our understanding of its biology and treatment. Molecular insights have provided important information on the development, heterogeneity, and risk factors of bladder cancer, as well as potential therapeutic targets. The field of molecular oncology has great potential in improving personalized care for bladder cancer patients.

CANCERS (2022)

添加到收藏夹

Article Cell Biology

Dynamic Changes in Myofibroblasts Affect the Carcinogenesis and Prognosis of Bladder Cancer Associated With Tumor Microenvironment Remodeling

YiHeng Du et al.

Summary: Myofibroblasts play a dual role in the development of bladder cancer, potentially providing protection but also impacting prognosis and treatment efficacy. In-depth research on myofibroblasts and the tumor microenvironment may lead to the discovery of potential diagnostic biomarkers and therapeutic targets for bladder cancer.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer

Zhengmao Wei et al.

Summary: The study found that the expression levels of SMARCC1 were increased in bladder cancer and were significantly associated with a higher T stage and poorer prognosis. Knockdown of SMARCC1 slowed cell growth, arrested the cell cycle, decreased migratory ability, and increased apoptotic cells. Therefore, SMARCC1 may be a potential diagnostic and therapeutic target for bladder cancer.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

添加到收藏夹

Article Cell Biology

A Comprehensive Transcriptomic Analysis of Arsenic-Induced Bladder Carcinogenesis

Vaibhav Shukla et al.

Summary: This study found that arsenic exposure can lead to malignant transformation of normal bladder epithelial cells, and stem cell activators play an important role in this process.

CELLS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway

Feng Tang et al.

Summary: NCAPG is overexpressed in bladder cancer, and its knockdown can inhibit cell proliferation through the inhibition of the NF-kappa B signaling pathway.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates

Victor Albarran et al.

Summary: Metastatic urothelial cancer is a major cause of cancer-related death, but new treatment approaches targeting Her-2 show promise, especially with the emergence of antibody-drug conjugates as a novel therapy for advanced cases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

添加到收藏夹

Article Urology & Nephrology

Castration immunoregulates toll-like receptor-4 in male bladder cancer

Leonardo Oliveira Reis et al.

Summary: TLR-4 expression in urothelial cells is modulated by castration and plays a role in cancer suppression and enhancement of immune response to BCG.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

The LMTK-family of kinases: Emerging important players in cell physiology and pathogenesis

Franz Wendler et al.

Summary: LMTKs are a novel family of serine/threonine specific kinases with diverse functions in cell signaling, membrane trafficking, and gene regulation. They play crucial roles in cell proliferation, differentiation, migration, and are implicated in neuropathologies and tumorigenesis, with potential as drug targets for various diseases. Their primary role may lie in endocytic cargo recycling and/or nuclear receptor transport pathways.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2021)

添加到收藏夹

Article Oncology

Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression

YiHeng Du et al.

Summary: This study revealed the significantly reduced expression of CXCL12 in BLCA compared with normal tissue, along with the reduced expression of various iCAFs marker genes in BLCA tissues. CXCL12 and iCAFs were associated with pathological features, TME remodeling, and aging in BLCA patients. iCAFs played dual roles in the carcinogenesis and progression of BLCA, impacting the prognosis and immunotherapy responsiveness for BLCA patients.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Article Oncology

RNF144A deficiency promotes PD-L1 protein stabilization and carcinogen-induced bladder tumorigenesis

Shiuh-Rong Ho et al.

Summary: The study reveals the tumor suppressor activity of RNF144A in vivo upon carcinogenic insult. Loss of RNF144A promotes the expression of DNA-PKcs, BMI1 and PD-L1, likely contributing to the carcinogen-induced bladder tumorigenesis.

CANCER LETTERS (2021)

添加到收藏夹

Article Oncology

BUB1 drives the occurrence and development of bladder cancer by mediating the STAT3 signaling pathway

Ning Jiang et al.

Summary: The study revealed that increased expression of BUB1 in human bladder cancer was associated with the activation of STAT3 signaling. Inhibition of BUB1 kinase activity effectively suppressed BCa cell proliferation and cancer progression both in vitro and in vivo. The BUB1/STAT3 complex played a critical role in promoting the transcription of STAT3 target genes, highlighting the potential of BUB1 as a therapeutic target for bladder cancer treatment.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

添加到收藏夹

Review Oncology

CircRNAs: Emerging Bladder Cancer Biomarkers and Targets

Zhaofeng Liang et al.

Summary: circRNAs, with their covalently closed loop structure, high stability, tissue specificity, and functional diversity, have been identified as potential biomarkers for bladder cancer. They have been shown to function in regulating gene transcription, acting as miRNA sponges, and encoding proteins.

FRONTIERS IN ONCOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients

Junhua Luo et al.

Summary: Techniques like reduced representation bisulfite sequencing and RNA sequencing were used to identify differentially methylated regions and expressed genes in bladder cancer tissues. The study found that hypermethylated lncRNAs, such as LINC00683 and MSC-AS1, could serve as potential prognostic biomarkers for bladder cancer.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Cell Biology

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer

Wenjie Luo et al.

Summary: The lncRNA RP11-89 promotes cell proliferation, migration, tumorigenesis and inhibits cell cycle arrest through the miR-129-5p/PROM2 axis in bladder cancer. RP11-89 acts as a sponge for miR-129-5p, upregulating PROM2 and activating iron export, leading to attenuation of ferroptosis. RP11-89 is a novel tumorigenic regulator that may serve as a potential biomarker for targeted therapy in bladder cancer.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Review Oncology

Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer

Hiroki Sekine et al.

Summary: NRF1 and NRF2, belonging to the same CNC transcription factor family, exhibit distinct functions in cancer cells. While NRF2 promotes tumorigenesis and resistance through metabolic reprogramming, NRF1 protects cancer cells by activating the proteasome bounce back response. The metabolite UDP-GlcNAc plays a key role in NRF1-mediated drug resistance.

CANCERS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Inhibitors of the Bub1 spindle assembly checkpoint kinase: synthesis of BAY-320 and comparison with 2OH-BNPP1

Ilma Amalina et al.

Summary: Bub1 is a serine/threonine kinase proposed to play a central role in mitotic chromosome alignment and the spindle assembly checkpoint, but its exact role in these processes remains controversial. Among two potential Bub1 inhibitors evaluated, BAY-320 showed more effective inhibition of Bub1 activity in cells.

ROYAL SOCIETY OPEN SCIENCE (2021)

添加到收藏夹

Review Oncology

Targetable Pathways in Advanced Bladder Cancer: FGFR Signaling

Jin-Fen Xiao et al.

Summary: This review discusses the presence of unfavorable genetic alterations in the FGFR3 gene in 20% of advanced bladder cancer patients and explores the potential therapeutic strategies targeting these alterations and mechanisms of drug resistance. It also highlights the clinical findings of combining FGFR inhibition with other targeted inhibitors and/or immunotherapy to improve outcomes for patients with suboptimal responses to FGFR3-directed monotherapy.

CANCERS (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells

Makoto Isono et al.

Summary: Combining MK-8776 with gemcitabine inhibits viability and colony formation of bladder cancer cells, induces apoptosis, and suppresses tumor growth in vivo. The combination treatment elevates gamma H2A.X and suppresses Rad51 expression, suggesting CHK1 inhibition combined with gemcitabine as a potential therapeutic strategy for bladder cancer.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Review Cell Biology

Sex Hormone Receptor Signaling in Bladder Cancer: A Potential Target for Enhancing the Efficacy of Conventional Non-Surgical Therapy

Hiroki Ide et al.

Summary: This article summarizes the involvement of sex hormone receptors, such as androgen receptor, estrogen receptor-alpha, and estrogen receptor-beta, in the progression of urothelial cancer, focusing on their modulation for the efficacy of conventional therapy and discusses their potential to overcome therapeutic resistance.

CELLS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Associations of genetically predicted circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 with bladder cancer risk

Chia-Wen Tsai et al.

Summary: Using a Mendelian randomization approach and genetic risk score, the study found a strong inverse relationship between circulating IGF-1 level and bladder cancer risk. However, circulating IGFBP-3 was not associated with bladder cancer risk.

MOLECULAR CARCINOGENESIS (2021)

添加到收藏夹

Article Biotechnology & Applied Microbiology

The circINTS4/miR-146b/CARMA3 axis promotes tumorigenesis in bladder cancer

Xiaotong Zhang et al.

CANCER GENE THERAPY (2020)

添加到收藏夹

Article Cell Biology

METTL3/YTHDF2 m6A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer

Haiyun Xie et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

添加到收藏夹

Article Pathology

Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder

Norihiko Masuda et al.

AMERICAN JOURNAL OF PATHOLOGY (2020)

添加到收藏夹

Article Oncology

Hsa_circ_0068307 mediates bladder cancer stem cell-like properties via miR-147/c-Myc axis regulation

Qi Chen et al.

CANCER CELL INTERNATIONAL (2020)

添加到收藏夹

Editorial Material Oncology

Why has the prognosis for muscle-invasive bladder cancer not significantly improved after decades of therapeutic advancements?

Takuro Goto et al.

EXPERT REVIEW OF ANTICANCER THERAPY (2020)

添加到收藏夹

Review Oncology

The Role of Steroid Hormone Receptors in Urothelial Tumorigenesis

Hiroki Ide et al.

CANCERS (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A Mechanism by which Ergosterol Inhibits the Promotion of Bladder Carcinogenesis in Rats

Nobutomo Ikarashi et al.

BIOMEDICINES (2020)

添加到收藏夹

Article Oncology

Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guerin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis

Taichi Mizushima et al.

MOLECULAR CANCER THERAPEUTICS (2020)

添加到收藏夹

Article Cell Biology

IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer

Wei Huang et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

LMTK3 promotes tumorigenesis in bladder cancer via the ERK/MAPK pathway

Tao Jiang et al.

FEBS OPEN BIO (2020)

添加到收藏夹

Article Oncology

5α-Reductase Inhibitors Do Not Prevent the Development and Progression of Urothelial Cancer: In Vitro Evidence

Yujiro Nagata et al.

BLADDER CANCER (2020)

添加到收藏夹

Review Urology & Nephrology

Organ preservation in bladder cancer: an opportunity for truly personalized treatment

Yee Pei Song et al.

NATURE REVIEWS UROLOGY (2019)

添加到收藏夹

Article Medicine, General & Internal

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma

Y. Loriot et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

添加到收藏夹

Article Multidisciplinary Sciences

ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer

Erica di Martino et al.

SCIENTIFIC REPORTS (2019)

添加到收藏夹

Review Cell Biology

Therapeutic Targeting of the IGF Axis

Eliot Osher et al.

CELLS (2019)

添加到收藏夹

Review Cell Biology

Safety Considerations in the Development of Hippo Pathway Inhibitors in Cancers

Satoko Kakiuchi-Kiyota et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)

添加到收藏夹

Article Multidisciplinary Sciences

Electronic-cigarette smoke induces lung adenocarcinoma and bladder urothelial hyperplasia in mice

Moon-shong Tang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)

添加到收藏夹

Article Urology & Nephrology

European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update

Morgan Roupret et al.

EUROPEAN UROLOGY (2018)

添加到收藏夹

Article Oncology

Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling

Satoshi Inoue et al.

MOLECULAR CANCER THERAPEUTICS (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Orally administered nicotine effects on rat urinary bladder proliferation and carcinogenesis

Shugo Suzuki et al.

TOXICOLOGY (2018)

添加到收藏夹

Review Oncology

The evolution of bladder cancer genomics: What have we learned and how can we use it?

Francois Audenet et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)

添加到收藏夹

Article Oncology

Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma

Shun-Jun Fu et al.

BMC CANCER (2018)

添加到收藏夹

Review Pharmacology & Pharmacy

Tp53 and its potential therapeutic role as a target in bladder cancer

Chiara Ciccarese et al.

EXPERT OPINION ON THERAPEUTIC TARGETS (2017)

添加到收藏夹

Review Oncology

Role of tumor microenvironment in tumorigenesis

Maonan Wang et al.

JOURNAL OF CANCER (2017)

添加到收藏夹

Article Pathology

An update on the molecular pathology of urinary bladder tumors

Peter G. Yousef et al.

PATHOLOGY RESEARCH AND PRACTICE (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson et al.

CELL (2017)

添加到收藏夹

Article Medicine, General & Internal

Nicotine, Carcinogen, and Toxin Exposure in Long-Term E-Cigarette and Nicotine Replacement Therapy Users A Cross-sectional Study

Lion Shahab et al.

ANNALS OF INTERNAL MEDICINE (2017)

添加到收藏夹

Review Urology & Nephrology

Spectrum of genomic alterations in FGFR3: current appraisal of the potential role of FGFR3 in advanced urothelial carcinoma

Nan Sethakorn et al.

BJU INTERNATIONAL (2016)

添加到收藏夹

Review Medicine, Research & Experimental

Controversial roles played by toll like receptor 4 in urinary bladder cancer; A systematic review

Amin Afsharimoghaddam et al.

LIFE SCIENCES (2016)

添加到收藏夹

Article Oncology

Androgen receptor activity modulates responses to cisplatin treatment in bladder cancer

Eiji Kashiwagi et al.

ONCOTARGET (2016)

添加到收藏夹

Article Oncology

Expression of androgen receptor in non-muscle-invasive bladder cancer predicts the preventive effect of androgen deprivation therapy on tumor recurrence

Koji Izumi et al.

ONCOTARGET (2016)

添加到收藏夹

Article Oncology

Global Cancer Statistics, 2012

Lindsey A. Torre et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2015)

添加到收藏夹

Review Oncology

Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity

Margaret A. Knowles et al.

NATURE REVIEWS CANCER (2015)

添加到收藏夹

Article Oncology

Androgen deprivation therapy prevents bladder cancer recurrence

Koji Izumi et al.

ONCOTARGET (2014)

添加到收藏夹

Article Integrative & Complementary Medicine

The investigation of a traditional Chinese medicine, Guizhi Fuling Wan (GFW) as an intravesical therapeutic agent for urothelial carcinoma of the bladder

Chi-Chen Lu et al.

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

添加到收藏夹

Article Oncology

Constitutive β-Catenin Activation Induces Male-Specific Tumorigenesis in the Bladder Urothelium

Congxing Lin et al.

CANCER RESEARCH (2013)

添加到收藏夹

Article Oncology

Androgen activates β-catenin signaling in bladder cancer cells

Yi Li et al.

ENDOCRINE-RELATED CANCER (2013)

添加到收藏夹

Editorial Material Chemistry, Medicinal

Small-molecule inhibitors of p21 as novel therapeutics for chemotherapy-resistant kidney cancer

Ruiwu Liu et al.

FUTURE MEDICINAL CHEMISTRY (2013)

添加到收藏夹

Article Urology & Nephrology

Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer

Masaki Shiota et al.

JOURNAL OF UROLOGY (2012)

添加到收藏夹

Article Oncology

Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells

Yichun Zheng et al.

ENDOCRINE-RELATED CANCER (2011)

添加到收藏夹

Review Urology & Nephrology

Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract

Veronique Phe et al.

BJU INTERNATIONAL (2009)

添加到收藏夹

Article Oncology

Promotion of bladder cancer development and progression by androgen receptor signals

Hiroshi Miyamoto et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)

添加到收藏夹

Article Oncology

Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer

Yoshiaki Yamamoto et al.

CANCER GENETICS AND CYTOGENETICS (2007)

添加到收藏夹

Article Pharmacology & Pharmacy

Enhanced urinary bladder and liver carcinogenesis in male CD1 mice exposed to transplacental inorganic arsenic and postnatal diethylstilbestrol or tamoxifen

Michael P. Waalkes et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.